We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALIT icon
11626
PUT
Alight
ALIT
$372M
$68K ﹤0.01%
500
-2,515
-83% -$412K
CELU icon
11627
CALL
Celularity
CELU
$20.1M
$68K ﹤0.01%
1,990
-3,270
-62% -$266K
NEXI
11628
DELISTED
NexImmune, Inc. Common Stock
NEXI
$68K ﹤0.01%
+1,693
New +$105K
SCUA.WS
11629
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$68K ﹤0.01%
295,011
+41,462
+16% +$9.38K
SDIG
11630
CALL
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$68K ﹤0.01%
4,120
-3,450
-46% -$109K
BYSI icon
11631
PUT
BeyondSpring
BYSI
$34.5M
$67K ﹤0.01%
46,400
-60,100
-56% -$100K
CLLS
11632
Cellectis
CLLS
$307M
$67K ﹤0.01%
+23,589
New +$83.1K
CPIX icon
11633
CALL
Cumberland Pharmaceuticals
CPIX
$117M
$67K ﹤0.01%
32,300
+18,100
+127% +$41.9K
GERN icon
11634
PUT
Geron
GERN
$943M
$67K ﹤0.01%
43,400
+2,500
+6% +$3.53K
IOBT
11635
DELISTED
IO Biotech
IOBT
$67K ﹤0.01%
+14,426
New +$88.3K
LSAK icon
11636
CALL
Lesaka Technologies
LSAK
$407M
$67K ﹤0.01%
+13,000
New +$64.6K
LU icon
11637
Lufax Holding
LU
$1.3B
$67K ﹤0.01%
2,811
-205,033
-99% -$4.76M
IMDX
11638
CALL
Insight Molecular Diagnostics
IMDX
$141M
$67K ﹤0.01%
3,700
-1,215
-25% -$27.6K
OTRK
11639
CALL
DELISTED
Ontrak
OTRK
$67K ﹤0.01%
707
+276
+64% +$38.6K
QNCX icon
11640
PUT
Quince Therapeutics
QNCX
$34.6M
$67K ﹤0.01%
152
-311
-67% -$220K
SIEB icon
11641
CALL
Siebert Financial
SIEB
$78.9M
$67K ﹤0.01%
42,900
+21,400
+100% +$39K
SIFY
11642
PUT
Sify Technologies
SIFY
$1.13B
$67K ﹤0.01%
5,750
-350
-6% -$4.95K
INFN
11643
PUT
DELISTED
Infinera Corporation Common Stock
INFN
$67K ﹤0.01%
12,500
-9,700
-44% -$62.1K
VIEW
11644
CALL
DELISTED
View, Inc. Class A Common Stock
VIEW
$67K ﹤0.01%
690
-1,027
-60% -$91.3K
RKTA.WS
11645
DELISTED
Rocket Internet Growth Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RKTA.WS
$67K ﹤0.01%
386,352
-94,846
-20% -$30.6K
GDEV
11646
DELISTED
Nexters Inc. Ordinary Shares
GDEV
$67K ﹤0.01%
10,507
ALLT icon
11647
PUT
Allot
ALLT
$383M
$66K ﹤0.01%
13,500
-31,500
-70% -$183K
BOXL icon
11648
Boxlight
BOXL
$4.64M
$66K ﹤0.01%
+68
New +$90.5K
CALC icon
11649
CALL
CalciMedica
CALC
$20.8M
$66K ﹤0.01%
4,293
+2,357
+122% +$32.2K
CIFR icon
11650
CALL
Cipher Digital
CIFR
$7.41B
$66K ﹤0.01%
48,100
-69,000
-59% -$168K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.